chr12-11031215-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_176885.2(TAS2R31):c.121A>T(p.Ile41Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_176885.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R31 | NM_176885.2 | c.121A>T | p.Ile41Phe | missense_variant | 1/1 | ENST00000390675.2 | NP_795366.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R31 | ENST00000390675.2 | c.121A>T | p.Ile41Phe | missense_variant | 1/1 | 6 | NM_176885.2 | ENSP00000375093.2 | ||
ENSG00000275778 | ENST00000703543.1 | c.-126+15805A>T | intron_variant | ENSP00000515364.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249984Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135610
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461814Hom.: 0 Cov.: 122 AF XY: 0.0000110 AC XY: 8AN XY: 727212
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152288Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.121A>T (p.I41F) alteration is located in exon 1 (coding exon 1) of the TAS2R31 gene. This alteration results from a A to T substitution at nucleotide position 121, causing the isoleucine (I) at amino acid position 41 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at